Iceland· IS-EU/1/25/2013/001
KYGEVVI
A doxecitine and doxribtimine product containing doxecitine,doxribtimine, registered in Iceland by UCB Pharma S.A.*. The same ATC class is registered in 9 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Doxecitine and doxribtimine is registered in 9 of 19 countries.
Countries holding a registration under ATC A16AX29 (doxecitine and doxribtimine), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Doxecitine and doxribtimine · ATC A16AX29
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Doxecitine,Doxribtimine
- Manufacturer
- UCB Pharma S.A.*
- Country
- Iceland (IS)
- ATC code
- A16AX29
- ATC class
- Doxecitine and doxribtimine
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Doxecitine and doxribtimine in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKYGEVVIUCB Pharma SA, Brusel
- FinlandKYGEVVIUCB Pharma SA
- FranceKYGEVVI 2 g/2 g, poudre pour solution buvableUCB PHARMA BELGIQUE
- IrelandKYGEVVI 2 g/2 g powder for oral solutionUCB Pharma S.A.
- NetherlandsKYGEVVI 2 g/2 g poeder voor drankUCB Pharma S.A.
- SwedenKYGEVVI 2 g/2 g Pulver till oral lösningUCB Pharma S.A.
- United StatesKYGEVVIUCB, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Kygevvi
- Norway · Kygevvi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f514c212-6ae9-4c7f-b56d-563449277e03 GET /v1/drugs/f514c212-6ae9-4c7f-b56d-563449277e03?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Mixtúruduft, lausn",
"source": "lyfjastofnun",
"atc_raw": "A16AX29",
"marketed": false,
"strength": "2 g/ 2 g",
"ma_number": "EU/1/25/2013/001",
"substance": "Doxecitine,Doxribtimine",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í erfðasjúkdómum og efnaskiptasjúkdómum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "46107"
}See everything about doxecitine and doxribtimine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.